Aglaia Oncology Funds
5 known investors
Aglaia is an investment firm that funds and co-founds early-stage oncology drug development companies, providing hands-on support in R&D planning from screening and animal studies through clinical trials. It focuses on maturing breakthrough cancer treatment inventions toward licensing, acquisition, or IPO.
Investors · 5
In the news
Frequently asked questions
- What does Aglaia Oncology Funds do?
- Aglaia is an investment firm that funds and co-founds early-stage oncology drug development companies, providing hands-on support in R&D planning from screening and animal studies through clinical trials. It focuses on maturing breakthrough cancer treatment inventions toward licensing, acquisition, or IPO.
- Who are Aglaia Oncology Funds's investors?
- Aglaia Oncology Funds's investors include BOM, Aurora Science, Cathay Venture, Korys, Oost NL.